World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
41323
World Ranking
11126
National Ranking
5725

Overview

Frank L. Meyskens is affiliated with the University of California, Irvine in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on Pharmaceutical Science, Oncology, Molecular Biology, Epidemiology, and Dermatology.

Their recent publications cover topics related to skin cancer chemoprevention, advanced drug delivery systems, and aging, including:

  • Topical Delivery of Carvedilol Loaded Nano-Transfersomes for Skin Cancer Chemoprevention, 2020, Pharmaceutics
  • Prediction of disability-free survival in healthy older people, 2022, GeroScience
  • Recent Advances in Clinical Research for Skin Cancer Chemoprevention, 2023, Cancers
  • Transfersome Encapsulated with the R-carvedilol Enantiomer for Skin Cancer Chemoprevention, 2023, Nanomaterials
  • Topical carvedilol delivery prevents UV-induced skin cancer with negligible systemic absorption, 2021, International Journal of Pharmaceutics

Frequent co-authors in Meyskens's publications include Bradley T. Andresen, Ayaz Shahid, Jeffrey Wang, Kristen M. Kelly, and Ying Huang. These collaborations have contributed to consistent research output in the fields noted above.

Publication venues where Meyskens's work appears frequently include:

  • Cancers
  • Pharmaceutics
  • GeroScience
  • Nanomaterials
  • International Journal of Pharmaceutics

Main research topics explored by Meyskens encompass:

  • Advancements in Transdermal Drug Delivery
  • Skin Protection and Aging
  • Cutaneous Melanoma Detection and Management
  • Lipid Membrane Structure and Behavior
  • Nonmelanoma Skin Cancer Studies
  • Advanced Drug Delivery Systems
  • Frailty in Older Adults

Best Publications

  • EFFECTS OF A COMBINATION OF BETA CAROTENE AND VITAMIN A ON LUNG CANCER AND CARDIOVASCULAR DISEASE

    Gilbert S. Omenn;Gary E. Goodman;Gary E. Goodman;Mark D. Thornquist;John Balmes

  • Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

    Scott M. Lippman;Eric A. Klein;Eric A. Klein;Phyllis J. Goodman;M. Scott Lucia

  • Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

    Eric A. Klein;Ian M. Thompson;Catherine M. Tangen;John J. Crowley

  • Risk Factors for Lung Cancer and for Intervention Effects in CARET, the Beta-Carotene and Retinol Efficacy Trial

    Gilbert S. Omenn;Gary E. Goodman;Mark D. Thornquist;John Balmes

  • Polyamines and cancer: old molecules, new understanding

    Eugene W. Gerner;Frank L. Meyskens

  • Reactive Oxygen Species: A Breath of Life or Death?

    John P. Fruehauf;Frank L. Meyskens

  • Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

    Jack Cuzick;Florian Otto;Florian Otto;John A Baron;Powel H Brown

  • Diagnosis and Treatment of Early Melanoma: NIH Consensus Development Panel on Early Melanoma

    Lowell A. Goldsmith;Frederic B. Askin;Alfred E. Chang;Cynthia Cohen

  • Development of difluoromethylornithine (DFMO) as a chemoprevention agent.

    Frank L. Meyskens;Eugene W. Gerner

  • Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

    Halle C F Moore;Joseph M. Unger;Kelly Anne Phillips;Frances Boyle;Frances Boyle

  • Prevention and early detection of prostate cancer

    Jack Cuzick;Mangesh A Thorat;Gerald L Andriole;Otis W Brawley;Otis W Brawley

  • Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: A randomized placebo-controlled, double-blind trial

    Frank L. Meyskens;Christine E. McLaren;Daniel Pelot;Sharon Fujikawa-Brooks

  • Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.

    Robert E. Carroll;Richard V. Benya;Danielle Kim Turgeon;Shaiju Vareed

  • The Beta-Carotene and Retinol Efficacy Trial: Incidence of Lung Cancer and Cardiovascular Disease Mortality During 6-Year Follow-up After Stopping β-Carotene and Retinol Supplements

    Gary E. Goodman;Mark D. Thornquist;John Balmes;Mark R. Cullen

  • Rationale and Strategies for Chemoprevention of Cancer in Humans

    John S. Bertram;Laurence N. Kolonel;Frank L. Meyskens

  • Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development: Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia

    Joyce A. O’Shaughnessy;Gary J. Kelloff;Gary B. Gordon;Andrew J. Dannenberg

  • Retinoids as preventive and therapeutic anticancer agents (Part I).

    Lippman Sm;Kessler Jf;Meyskens Fl

  • Quality of Life End Points in Cancer Clinical Trials: Review and Recommendations

    Carol McMillen Moinpour;Polly Feigl;Barbara Metch;Katherine A. Hayden

  • Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.

    Dennis J. Ahnen;Polly Feigl;Gang Quan;Cecelia Fenoglio-Preiser

  • Goserelin for Ovarian Protection During Breast-Cancer Adjuvant Chemotherapy

    Halle C.F. Moore;Joseph M. Unger;Kelly Anne Phillips;Frances Boyle;Frances Boyle

Frequent Co-Authors

David S. Alberts
David S. Alberts University of Arizona
Eugene W. Gerner
Eugene W. Gerner University of Arizona
Hoda Anton-Culver
Hoda Anton-Culver University of California, Irvine
Scott M. Lippman
Scott M. Lippman University of California, San Diego
Sydney E. Salmon
Sydney E. Salmon University of Arizona
Eric A. Klein
Eric A. Klein Cleveland Clinic
Dawn L. Hershman
Dawn L. Hershman Columbia University
Ian M. Thompson
Ian M. Thompson The University of Texas Health Science Center at San Antonio
Timothy R. Morgan
Timothy R. Morgan California State University, Long Beach
Gilbert S. Omenn
Gilbert S. Omenn University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA doesn’t have to mean following a single, traditional route. For those looking for flexibility or different entry points into the healthcare field, a variety of online degrees and career pathways are available.

If you already hold an RN license and are seeking to advance your career, you can explore what is the cheapest rn to bsn program online to help you earn your BSN affordably. For individuals who do not have a nursing background but want to become a nurse practitioner, direct entry nurse practitioner programs for non-nurses online offer a fast-tracked option.

Non-nurses interested in an entry-level role can consider online adn programs for non nurses, which can be less competitive to access and completed online. For those interested in healthcare but not in clinical roles, online medical coding classes with financial aid present another viable pathway into the medical field.

These flexible online options make it easier to start or advance a healthcare career without the barriers of traditional classroom learning.

Best Scientists Citing Frank L. Meyskens

Trending Scientists

Recently Published Articles